Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Receivables - Other (2016 - 2024)

Historic Receivables - Other for National Healthcare (NHC) over the last 15 years, with Q4 2024 value amounting to $19.0 million.

  • National Healthcare's Receivables - Other fell 38.85% to $19.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $19.0 million, marking a year-over-year decrease of 38.85%. This contributed to the annual value of $19.0 million for FY2024, which is 38.85% down from last year.
  • Per National Healthcare's latest filing, its Receivables - Other stood at $19.0 million for Q4 2024, which was down 38.85% from $19.0 million recorded in Q4 2023.
  • Over the past 5 years, National Healthcare's Receivables - Other peaked at $19.0 million during Q4 2023, and registered a low of $18.8 million during Q4 2022.
  • Moreover, its 5-year median value for Receivables - Other was $19.0 million (2020), whereas its average is $18.9 million.
  • In the last 5 years, National Healthcare's Receivables - Other tumbled by 92.44% in 2020 and then soared by 109.32% in 2023.
  • National Healthcare's Receivables - Other (Quarter) stood at $19.0 million in 2020, then decreased by 0.33% to $18.9 million in 2021, then decreased by 0.34% to $18.8 million in 2022, then rose by 1.09% to $19.0 million in 2023, then decreased by 0.39% to $19.0 million in 2024.
  • Its Receivables - Other was $19.0 million in Q4 2024, compared to $19.0 million in Q4 2023 and $18.8 million in Q4 2022.